author-photo

Suman Paul

Johns Hopkins University School of Medicine

4

Papers

21

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Targeting loss of heterozygosity for cancer-specific immunotherapy.

2021 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (6)
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: a Retrospective Cohort Study.

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (8)
Targeting MHC-linked wild type p53 with TCR mimic single chain diabody for cancer immunotherapy.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplant Cyclophosphamide in Chronic Lymphocytic Leukemia.

2019 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (6)